- Home
- ORKT vs IMRX Comparison
ORKT vs IMRX Comparison
Compare ORKT & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORKT
- IMRX
- Stock Information
- Founded
- ORKT 2003
- IMRX 2008
- Country
- ORKT Singapore
- IMRX United States
- Employees
- ORKT N/A
- IMRX N/A
- Industry
- ORKT
- IMRX Biotechnology: Pharmaceutical Preparations
- Sector
- ORKT
- IMRX Health Care
- Exchange
- ORKT NYSE
- IMRX Nasdaq
- Market Cap
- ORKT 82.9M
- IMRX 73.2M
- IPO Year
- ORKT 2024
- IMRX 2021
- Fundamental
- Price
- ORKT $3.07
- IMRX $1.94
- Analyst Decision
- ORKT
- IMRX Buy
- Analyst Count
- ORKT 0
- IMRX 7
- Target Price
- ORKT N/A
- IMRX $12.60
- AVG Volume (30 Days)
- ORKT 2.7M
- IMRX 369.8K
- Earning Date
- ORKT 11-19-2024
- IMRX 11-13-2024
- Dividend Yield
- ORKT N/A
- IMRX N/A
- EPS Growth
- ORKT N/A
- IMRX N/A
- EPS
- ORKT N/A
- IMRX N/A
- Revenue
- ORKT $3,904,592.00
- IMRX N/A
- Revenue This Year
- ORKT N/A
- IMRX N/A
- Revenue Next Year
- ORKT N/A
- IMRX N/A
- P/E Ratio
- ORKT N/A
- IMRX N/A
- Revenue Growth
- ORKT N/A
- IMRX N/A
- 52 Week Low
- ORKT $1.45
- IMRX $1.00
- 52 Week High
- ORKT $8.00
- IMRX $8.89
- Technical
- Relative Strength Index (RSI)
- ORKT N/A
- IMRX 51.04
- Support Level
- ORKT N/A
- IMRX $1.68
- Resistance Level
- ORKT N/A
- IMRX $1.97
- Average True Range (ATR)
- ORKT 0.00
- IMRX 0.13
- MACD
- ORKT 0.00
- IMRX -0.01
- Stochastic Oscillator
- ORKT 0.00
- IMRX 71.72
About ORKT ORANGEKLOUD TECHNOLOGY INC
Orangekloud Technology Inc is a company that operates through its subsidiaries provide IT consultancy services and distribution of related products and services. The Company also offers ERPs predominately in Singapore. It derives revenue from platform subscriptions, license and products and professional services.
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.